Advances in the treatment of non-Hodgkin's lymphoma.
Cerny
T
T
Department of Internal Medicine, Division of Oncology and Hematology, Kantonsspital St Gallen, St Gallen, Switzerland.
Gillessen
S
S
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001707:Biopsy, Needle; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D005260:Female; D006085:Graft Survival; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000401:mortality / Q000473:pathology / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal